RQ
The drug-drug interaction risk was mitigated by the lack of CYP inhibition.
The drug-drug interaction risk was mitigated by the lack of CYP inhibition.
Avantor Inc. (Radnor, PA). 2024 revenue ~$6.8B. Lab chemicals (J.T.Baker, Macron, BDH brands), biopharma production materials. Mission: clinical diagnostics, research, biopharma.
The exposure margins are sufficient for the proposed clinical dose.